At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.
Our fundraising tracker provides updated coverage of noteworthy digital health and health tech funding rounds, though we'll still profile exciting new companies and larger rounds that catch our eye in depth.
Do you have fundraising news to share? Email Senior Editor Heather Landi at hlandi@questex.com.
Previous fundraising tracker updates can be found here and here. For news about funding deals from 2023, check out our 2023 Fundraising Tracker.
European full-body scan startup Neko Health banks $260M
London-based Neko Health, a company co-founded by Hjalmar Nilsonne and Spotify's Daniel Ek, picked up $260 million in series B funding. The round was led by Lightspeed Venture Partners with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar and Atomico.
The startup launched in February 2023 and has now completed 10,000 scans across Stockholm and London. The company says demand remains high, with the global waiting list totaling more than 100,000. Neka Health is now building out capacity with further locations and new regions.
The funding will help accelerate company's plans for expansion within Europe and the U.S. and continued investment in R&D for new breakthrough health diagnostics, according to a press release.
The company picked up $65 million in series A funding in July 2023, which saw Lakestar, Atomico and General Catalyst join original investor Prima Materia.
The Neko Health scan costs 299 pounds sterling (about $368) and maps millions of health data points on the body, according to the company. It checks moles and marks across the body, symptoms of metabolic syndrome and risk factors for stroke and heart attack, along with blood sugar levels to assess prediabetes risk. Additionally, it checks for skin cancer and blood abnormalities.
Solera Health picks up $40M series E funding
Healthcare technology company Solera Health picked up $40 million in series E funding backed by Health Care Service Corporation, Adams Street, Cobalt Ventures and Horizon Mutual Holdings Inc.
The company will use the new financing to expand access to digital health support.
Solera Health is a benefits network that connects patients, payers and physicians with a curated network of digital health programs and services.
The company said it will utilize the funding to expand its HALO platform, which is built on cloud technology to unite the Solera network of value-based point solutions within its marketplace. That simplifies the addition of hundreds of digital health applications for better access and speed of integration, according to the company. Solera's approach also facilitates efficient, cost-effective operational support for turnkey digital health programs for payers and employers.
Last year, the company added virtual specialty care to its platform and also introduced solutions targeting cardiometabolic health challenges like hypertension, high cholesterol, diabetes prevention and weight management.
Solera also announced that interim CEO John Santelli, who joined the company in March 2024, transitioned to the role of CEO.
French medtech startup raises $28M for neurosurgical microrobots
Paris-based Robeauté nabbed $28 million led by Plural, Cherry Ventures and Kindred Ventures. Other investors including LocalGlobe, Think.Health and previous investors APEX Ventures participated, along with strategic investment from Brainlab.
Robeauté will use the funding to continue developing its technology, starting human trials in 2026 and setting up U.S. operations ahead of FDA approval and full go-to-market, the company said in a press release.
The company developed what it calls microrobots that come in at the size of a grain of rice.
"Neurological disorders are difficult to diagnose in the early stages when intervention can have the most impact. Modern neurosurgery still relies on relatively crude methods, with stiff tools pushed through the brain in a straight line, impeding multi-site access and precise targeting," executives said in the press release. "Pharmaceutical treatments struggle to make an impact due to the complexities of crossing the blood-brain barrier to reach the site of interest."
Robeauté’s microrobots can move along curved routes through the extracellular matrix to safely reach multiple sites of interest and carry out required tasks. The company said its modular medical devices are ideal to deliver molecules, implant an electrode and collect cell or live data samples through sensors.
Founder Bertrand Duplat spent 30 years in robotics, including at McGill University in Montreal and the European Space Agency, specializing in developing robots in extreme environments. He founded a 3D software company, Virtools (sold to Dassault Systèmes), before starting Robeauté with co-founder Joana Cartocci, an operations specialist, when his mother was diagnosed with glioblastoma.
Percipio Health launches with $20M for smartphone-based pop health
Population health platform Percipio Health officially launched this week armed with $20 million.
UPMC Enterprises, the health system's venture arm, WAVE Ventures, Labcorp and First Trust Capital Partners backed the company's series A round.
The Plano, Texas-based startup developed a platform that uses artificial intelligence and a smartphone—without medical monitoring devices—to collect and analyze "whole-person health signals for real-time assessments that identify current and predictive health risks," the company said in a press release.
Providers and payers can use these insights as a shared source of truth to manage growing populations and move value-based care contracting forward, the company said.
The aim of the technology is to reach broader populations at lower costs while reducing risk and advancing value-based care.
"Asynchronous monitoring is among the most powerful tools for the future of healthcare, enabled by the efficiencies of AI," Andrew Watson, M.D., a professor of surgery in the division of colorectal surgery at UPMC and senior medical adviser at UPMC Enterprises, said in a statement.
"This ability to make the patient's phone a pivotal part of health care may provide powerful health insights, second only to genetics," Watson said.
The platform works by using a single mobile app to collect multiple health signals daily. It uses vision-based AI biomarkers for vitals and medication monitoring and vocal AI biomarkers for brain health assessments.
Percipio's co-founders are Eric Rock and David Lucas, recognized as veterans in digital health, having previously started Vivify Health, a remote patient monitoring platform that was acquired by UnitedHealth Group's Optum division in 2019, and Medhost, an emergency department medical records and workflow solution that was acquired by HealthTech Holdings in 2010.
UPMC Enterprises, Memorial Hermann Health System invest in Spark Pediatrics
Spark Pediatrics, an operator of Prescribed Pediatric Extended Care, picked up a new capital investment of $15 million to help provide access to care for children with medical complexities.
The round includes new strategic investments and relationships with UPMC Enterprises, Memorial Hermann Health System and other leading health plans, health systems and financial investors, the company said.
Spark Pediatrics operates a center-based, team-orientated care delivery model that is staffed by pediatric skilled nurses and other care providers. This approach allows for an improvement in health and social determinants of health outcomes, such as reducing length of stay in the NICU and 30-day readmissions as well as increasing socialization and respite for children and their families, according to the company.
There are more than 3 million children in the U.S. who are defined as “medically complex,” meaning they have life-threatening conditions that affect two or more organ systems, with this number expected to double over the next decade. Two-thirds of these children are covered by Medicaid and struggle to access the skilled nursing services needed to thrive.
The new capital will be used to fuel Spark Pediatrics' growth in new markets outside of Florida, including Texas and Pennsylvania, and to expand value-based offerings in partnership with health systems and health plans for medically complex children.
“Spark is creating a new model of care delivery for children with medical complexities that is aimed at improving quality of care and the family experience for this often-overlooked population,” said Mary Beth Navarra-Sirio, vice president of market development at UPMC Enterprises, the venture capital arm of health system UPMC, in a statement. “This aligns well with our focus on creating innovations that impact the lives of patients in meaningful, lasting ways. We are thrilled to support Spark in bringing this innovative option to more children and families.”
IntusCare nabs $11.5 million follow-on financing round
IntusCare, a company that provides predictive analytics solutions for geriatric care, increased total funding to $27 million with a strategic follow-on financing round of $11.5 million.
The investment round was led by Deerfield Management with participation from Citi Impact Fund, Jumpstart Nova and other existing IntusCare investors.
The company plans to use the fresh capital to support the launch of CareHub, a comprehensive care management platform. The new funding also will fuel the expansion of IntusCare’s existing suite of revenue integrity, population health and utilization management solutions. And, the company will accelerate its artificial intelligence research, aiming to enhance user experiences for healthcare providers and staff.
IntusCare initially focused on Programs of All-Inclusive Care for the Elderly programs. The company is strategically positioned to expand its product suite to serve accountable care organizations and special needs plans. The company’s solutions are particularly valuable for organizations taking on risk in complex Medicare and Medicaid populations, executives said.
IntusCare co-founders Robbie Felton and Evan Jackson launched the company in 2019 while they were both Brown University undergraduate students.
The company secured series A funding of $14.1 million in November 2022.
Teal Health nabs $10M to launch at-home cervical cancer screening device
Teal Health, a women’s health company, closed an additional $10 million in seed funding, led by Emerson Collective and Forerunner with continued support from existing investors such as Serena Ventures, Metrodora and new partner Labcorp.
Teal Health is gearing up to launch its Teal Wand device, which is currently under FDA review and on track to be the U.S. market's first FDA-approved at-home self-collect cervical cancer screening device. This new capital brings Teal Health’s funding to $23 million to date as the company accelerates its product development and readies go-to-market plans.
The startup's recent milestones include a $1.68 million Small Business Innovation Research grant from the National Cancer Institute and FDA breakthrough device designation.
Teal Health is focused on increasing the rate of cervical cancer screening. Currently, 92 million U.S. women and people with a cervix are of screening age, but 1 in 4 are not screening routinely due to limited access and discomfort with the invasive exam.
The U.S. Preventive Services Task Force has included self-collection in its recent draft recommendations, recognizing its role in increasing adherence to screening.
hc1 closes $6.25M funding round for lab management solutions
A company that turns lab data into actionable intelligence picked up $6.25 million in new financing.
Existing investor Health Cloud Capital led the investment in hc1 with participation from health tech investment firm A1 Health Ventures. Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.
In October, hc1 acquired healthcare performance consulting company Accumen. The funding will support launching enhanced solutions that couple hc1 and Accumenʼs technology and expertise.
The company plans to use the funding to empower lab stewardship to ensure patients are tested, diagnosed and proactively managed; optimize patient blood management and proactively managing patients with anemia to improve outcomes and reduce costs; eliminate waste in the supply chain; ensuring staffing levels are ideally aligned utilizing advanced analytics, AI, benchmarking and implanting best practices, the company said in a press release.
Behavioral health solution Peregrine Health pockets $5M
Peregrine Health, a provider of behavioral health solutions for underserved communities, secured $5 million in funding to expand its services. The new capital will fuel the company's continued growth as a partner for Federally Qualified Health Centers and Rural Health Clinics.
Peregrine Health, which officially launched in early 2023, helps these organizations build sustainable, tech-enabled behavioral health programs.
The funding round was led by BIP Ventures, Martin Ventures and Chapman Capital.
Peregrine's approach integrates expert clinicians, operational support and advanced technology into healthcare partner organizations. Unlike traditional behavioral health solutions, Peregrine offers a fully managed service line, empowering clinics to overcome persistent challenges such as provider shortages, operational inefficiencies and scalability limitations, according to the company.
The company plans to use the funding to invest in technology and program development. The recent funding round will fuel the rollout of innovative offerings like outcome tracking, telehealth integration and collaborative care models.